Braun J, Kiltz U, Andreica I, Buehring B, Guminski B, Häusler U, Kavruk H, Kiefer D, Lochowski R, Mintrop B, Baraliakos X
Rheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
Z Rheumatol. 2019 Oct;78(8):753-764. doi: 10.1007/s00393-019-0663-2.
The Ruhrgebiet Rheumatism Center, which is highly specialized for rheumatic diseases, is the largest of its kind in Germany. For many years it has fulfilled all the requirements for structural quality required by the Association of Rheumatological Acute Clinics (VRA) including regular participation in the KOBRA benchmarking project. Therefore, the center regularly receives the VRA seal for quality of care. In 2018 more than 7500 patients were treated as inpatients. Within the framework of care according to §116b (ASV since May 2019) there were nearly 25,000 outpatient patient contacts. Furthermore, an early screening program (triage) was established 5 years ago in order to be able to identify patients with musculoskeletal complaints on a potentially inflammatory rheumatic basis. This functions in the sense of an early diagnosis and treatment in accordance with the treat-to-target concept within less than 4 weeks (initially) on an outpatient basis with respect to the required urgency, in order to subsequently provide sound diagnostic support. In the last 2 years 2017 and 2018, this deadline was met in more than 90% of cases. Within the scope of inpatient care approximately one third of patients were treated in recent years with a defined rheumatological complex therapy and 10% with pain complex therapy. Approximately 3% were treated with geriatric complex therapy and 65% were short-stay patients (<4 days), i.e. patients who received the necessary diagnostics and treatment on an inpatient basis at short notice. The overall structure of the rheumatism center, the cooperation with rheumatologists in private practice, many cooperation partners, referring physicians and patients represents a model for rheumatological care in large conurbations. The care of large numbers of patients also enables the further training of many assistants and this is essential for the future of good rheumatological medicine.
鲁尔区风湿病中心是德国同类机构中规模最大的,在风湿病治疗方面高度专业化。多年来,它一直满足风湿病急性诊所协会(VRA)对结构质量的所有要求,包括定期参与KOBRA基准项目。因此,该中心经常获得VRA的医疗质量认证。2018年,超过7500名患者接受了住院治疗。在根据§116b(自2019年5月起为ASV)提供护理的框架内,有近25000次门诊患者就诊。此外,5年前设立了一项早期筛查计划(分诊),以便能够识别有肌肉骨骼疼痛症状、可能基于炎性风湿病的患者。这一计划按照治疗靶点概念,在门诊基础上针对所需的紧急情况,在不到4周(最初)的时间内实现早期诊断和治疗,以便随后提供可靠的诊断支持。在2017年和2018年这两年中,超过90%的病例达到了这一期限。在住院护理范围内,近年来约三分之一的患者接受了明确的风湿病综合治疗,10%的患者接受了疼痛综合治疗。约3%的患者接受了老年病综合治疗,65%为短期住院患者(<4天),即在短时间内接受了必要的住院诊断和治疗的患者。风湿病中心的整体结构、与私人执业风湿病医生的合作、众多合作伙伴、转诊医生和患者代表了大城市风湿病护理的典范。大量患者的护理也使得许多助理人员能够得到进一步培训,这对未来优质风湿病医学至关重要。